Zimbabwe and South Africa first in approval of Dapivirine Vaginal Ring

Zimbabwe and South Africa first in approval of Dapivirine Vaginal Ring

Zimbabwe and South Africa are now the first African countries to introduce the Dapivirine Vaginal Ring as part of their prevention package, and are giving hope to adolescent girls and young women in Sub-Saharan Africa. The Dapivirine Vaginal Ring is the first discreet, women-controlled, long-acting HIV prevention option available. It is an important new option for women, who are disproportionally affected by HIV. In 2020, the World Health Organization (WHO) recommended the Dapivirine Vaginal Ring as an additional HIV prevention tool.

Follow the good example

Aidsfonds is supporting the EmpoweRing: Prevention by Choice Project by International Community of Women Living with HIV Eastern Africa (ICWEA) to reduce new HIV infections among women and girls in East Africa through adoption of Dapivirine Ring as an HIV prevention tool. There is positive feedback on acceptance of the ring in Uganda and Kenya (not official and public approval) that provide the light of  East African women to prevent HIV by choice.

We are calling upon countries in the African region to follow the good example of South Africa and Zimbabwe, to speed up the process of approval of the Dapivirine Vaginal Ring, and making it accessible for all (young) women.

 

Header image courtesy of IPM

 

Aidsfonds.org uses cookies to offer the best website experience possible and to anonymously analyze website behaviour. More information.